Michael Benkowitz
2019
In 2019, Michael Benkowitz earned a total compensation of $19.6M as President and Chief Operating Officer at United Therapeutics, a 197% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $2,829,195 |
|---|---|
| Non-Equity Incentive Plan | $940,313 |
| Option Awards | $15,003,750 |
| Salary | $845,577 |
| Other | $17,171 |
| Total | $19,636,006 |
Benkowitz received $15M in option awards, accounting for 76% of the total pay in 2019.
Benkowitz also received $2.8M of change in pension value and nonqualified deferred compensation earnings, $940.3K in non-equity incentive plan, $845.6K in salary and $17.2K in other compensation.
Rankings
In 2019, Michael Benkowitz's compensation ranked 160th out of 13,971 executives tracked by ExecPay. In other words, Benkowitz earned more than 98.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 160 out of 13,971 | 99th |
Division Manufacturing | 58 out of 5,701 | 99th |
Major group Chemicals And Allied Products | 16 out of 2,200 | 99th |
Industry group Drugs | 12 out of 1,886 | 99th |
Industry Pharmaceutical Preparations | 11 out of 1,398 | 99th |
Source: SEC filing on April 29, 2022.
Benkowitz's colleagues
We found three more compensation records of executives who worked with Michael Benkowitz at United Therapeutics in 2019.